International Stem Cell Corp., a California-based biotechnology company focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products, announced earlier today that Dr. Simon Craw, Executive Vice President of Business Development and Investor Relations, will be giving a presentation at the 2012 Southern California Investor Conference on Thursday, August 30, 2012, at 2:30 pm PT / 5:30 pm ET.
Held at the Marriott Hotel in Newport Beach, California, the conference is open to the public. Attendees will enjoy company presentations, a gourmet luncheon, free copy of California Stock Report, and much more. Investors who wish to arrange a meeting with International Stem Cell's management team should contact Mark McPartland with MZ Group via email email@example.com or phone 1-212-301-7130.
For additional information on ISCO, visit the company's website at InternationalStemCell.com
Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net